INOVIO PHARMACEUTICALS INC (INO)
US45773H4092 - Common Stock
Which stocks are moving before the opening bell on Tuesday?
Discover the top movers in Tuesday's pre-market session and stay informed about market dynamics.
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Tuesday
Pre-market stock movers are worth diving into on Tuesday as we check out all of the biggest changes and the news behind them!
INOVIO to Participate in The Citizens JMP Novel Therapeutics Forum at Penn Medicine
/PRNewswire/ -- INOVIO (NASDAQ:INO), a biotechnology company focused on developing and commercializing DNA medicines to help treat and protect people from...
Inovio Pharmaceuticals (INO) Q4 2023 Earnings Call Transcript
INO earnings call for the period ending December 31, 2023.
INO Stock Earnings: Inovio Pharmaceuticals Beats EPS, Misses Revenue for Q4 2023
INO stock results show that Inovio Pharmaceuticals beat analyst estimates for earnings per share but missed on revenue for the fourth quarter of 2023.
INO Stock Earnings: Inovio Pharmaceuticals Beats EPS, Misses Revenue for Q4 2023
InvestorPlace - Stock Market News, Stock Advice & Trading Tips Inovio Pharmaceuticals (NASDAQ:INO) just reported results for the fourth quarte...
INOVIO Reports Fourth Quarter and Full Year 2023 Financial Results and Operational Highlights
Announced substantial progress with lead program, INO-3107, as potential treatment for Recurrent Respiratory Papillomatosis (RRP) Positive data announced from...
INOVIO to Present at the Oppenheimer 34th Annual Healthcare Life Sciences Conference
/PRNewswire/ -- INOVIO (NASDAQ:INO), a biotechnology company focused on developing and commercializing DNA medicines to help treat and protect people from...
INOVIO Reports Inducement Grant Under Inducement Plan
/PRNewswire/ -- INOVIO (NASDAQ:INO), a biotechnology company focused on developing and commercializing DNA medicines to help treat and protect people from...
Inovio stock upgraded at Oppenheimer on lead drug (NASDAQ:INO)
Oppenheimer upgrades Inovio Pharmaceuticals (INO), citing its investigational therapy for recurrent respiratory papillomatosis (RRP). Read more here.
SAP Layoffs 2024: What to Know About the Latest SAP Job Cuts
SAP layoffs are coming for 8,000 of the company's employees as it prepares to switch focus to the development of AI tools.
eBay Layoffs 2024: What to Know About the Latest EBAY Job Cuts
eBay layoffs are one the way for 9% of the company's workforce as the company prepares to cut 1,000 jobs to reduce expenses.
Why Is Inovio Pharmaceuticals (INO) Stock Down Today?
Inovio Pharmaceuticals stock is falling on Wednesday as the company prepares for a one-for-12 reverse stock split for INO.
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Wednesday
It's time to dive into the biggest pre-market stock movers on Tuesday with a breakdown of all the latest news affecting shares this morning.
INOVIO Announces Effective Date of 1-for-12 Reverse Stock Split
/PRNewswire/ -- INOVIO (NASDAQ:INO), a biotechnology company focused on developing and commercializing DNA medicines to help treat and protect people from...
INOVIO to Participate in Virtual Fireside Chat on the Potential Treatment of Recurrent Respiratory Papillomatosis with Key Opinion Leader
/PRNewswire/ -- INOVIO (NASDAQ: INO), a biotechnology company focused on developing and commercializing DNA medicines to help treat and protect people from...
Inovio stock surges to seven-month high (NASDAQ:INO)
Inovio Pharmaceuticals (INO) stock surges to reach a seven month high on the back of a clinical trial pact and a plans to file a marketing application. Read more here.
Inovio plans to submit BLA to FDA for INO-3107 in 2H (NASDAQ:INO)
Inovio (INO) is aiming to submit a Biologics License Application for its drug INO-3107 to the FDA under the accelerated approval program. Read more here.
Bank of America favorable on SMID-cap biotechs into 2024
Biotech stocks gain as Bank of America takes a more positive view on SMID-cap stocks and specialty pharma. Read more here.
The 3 Most Undervalued Biotech Stocks to Buy: November 2023
Given the undervalued biotech industry, these three undervalued biotech stocks to buy are ripe purchase targets for high-potential profits.
The 3 Most Undervalued Biotech Stocks to Buy: November 2023
InvestorPlace - Stock Market News, Stock Advice & Trading Tips These companies in the biotechnology sector are doing incredible work and achie...
Inovio Pharmaceuticals (INO) Q3 2023 Earnings Call Transcript
INO earnings call for the period ending September 30, 2023.
Inovio files for $300M mixed shelf (NASDAQ:INO)
Inovio Pharmaceutics plans to raise $300 million through the sale of common stock, preferred stock, debt securities, and warrants. Read more.